Katherine Peil
Adult Medicine · Sumter, SCNPI 1467061481
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 435 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 34 manufacturers reported payments, led by AbbVie at 30.3% of the total. 2025 is the largest year on record at $2,540, 6.6 times the $387 reported in 2021.
Across 435 payments — averaging $18.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$725
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$719
- Lilly USA, LLC$474
- Takeda Pharmaceuticals U.S.A., Inc.$413
- Phathom Pharmaceuticals, Inc.$346
- plus $3K from 28 others
What the payments were for
- Food & beverage$7,97899%
- Education$521%
- Gifts$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 157 | $2,435 |
| Johnson & Johnson(2 entities) | 41 | $725 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 42 | $719 |
| Lilly USA, LLC | 22 | $474 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $413 |
| Phathom Pharmaceuticals, Inc. | 15 | $346 |
| Sanofi | 13 | $343 |
| QOL Medical, LLC | 10 | $277 |
| Merck | 14 | $269 |
| Ironwood Pharmaceuticals, Inc | 12 | $212 |
| Pfizer | 9 | $187 |
| Madrigal Pharmaceuticals | 11 | $181 |
| Bristol Myers Squibb | 11 | $167 |
| Daiichi Sankyo Inc. | 6 | $140 |
| Ardelyx, Inc. | 5 | $127 |
| Braintree Laboratories, Inc. | 5 | $105 |
| Aimmune Therapeutics, Inc. | 5 | $103 |
| Biocon Biologics Inc | 4 | $88 |
| E.r. Squibb & Sons, L.L.C. | 1 | $78 |
| Nestle Healthcare Nutrition Inc. | 4 | $77 |
| Ipsen Biopharmaceuticals, Inc | 3 | $77 |
| Celltrion USA Inc. | 4 | $75 |
| Intercept Pharmaceuticals, Inc. | 3 | $57 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| Neuraxis, Inc. | 1 | $46 |
| Novo Nordisk | 2 | $46 |
| Redhill Biopharma Inc. | 3 | $44 |
| Medtronic | 2 | $41 |
| Lucid Diagnostics Inc. | 2 | $40 |
| Ferring Pharmaceuticals Inc. | 2 | $37 |
| Boehringer Ingelheim | 1 | $17 |
| Amgen | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| Eisai Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few adult medicine providers in South Carolinato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 56 | $9,499 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 58 | $3,633 |
| Colestipol Hcl | 23 | $2,258 |
| SuflavePeg 3350/Sod Sulf,chlr/Pot/Mag | 16 | $1,967 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 98 | $1,690 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 59 | $988 |
| Omeprazole | 12 | $262 |
| Famotidine | 19 | $239 |
| Pantoprazole Sodium | 14 | $155 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Ferring Pharmaceuticals Inc.Clenpiq | $37 | $9,49956 claims |
| Braintree Laboratories, Inc.Suflave | $105 | $1,96716 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few adult medicine providers in South Carolinaon file to place this against a meaningful peer group, so we don't.
Other adult medicine in Sumter
- Alfred MossGaffney$14K
- Melanie MoleEasley$2K
- Jose Morales VazquezMyrtle Beach$2K
- Elaine Inman-WilliamsonAiken$2K
- Samai SupanOkatie$713
- Yvette-Marie PellegrinoBeaufort$635
- Kelly PassarelloSummerville$482
- Kelley MoodyHartsville$290
- Kelsey SeptimioFort Mill$229
- Samuel OrrGaffney$157
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.